Prediction Case File
YouTubePartially Resolved

November was a tough month for obscure small-cap stocks, but the ultimate insiders still landed some huge gains even as the rest of the market sank. Members of Congress scored big on a few little-known names — while others took major hits. We break down six obscure congressional trades that outperfo

3 extracted signals · 2 resolved · 1 still active

MarketBeat profile imageMarketBeat29 Nov 2025, 19:01 UTC
Video preview for November was a tough month for obscure small-cap stocks, but the ultimate insiders still landed some huge gains even as the rest of the market sank. Members of Congress scored big on a few little-known names — while others took major hits. We break down six obscure congressional trades that outperfo
Signals
3
Eligible signals in this source
Open
1
Still being tracked
Resolved
2
Evaluable outcomes
Successful
1
Canonical correct result
Failed
1
Canonical failed result
Resolved success
50%
Open and excluded signals omitted
Source overview

AI-generated source summary

The video analyzes congressional trading data, highlighting stocks with notable activity in November. It identifies LCII as having a 25.9% increase since late October following congressional purchases between 1 and 5 million, potentially driven by a market recovery. Conversely, LGIH is down 32.6% since October 27, despite a purchase in the 15,000-50,000 range, with poor earnings potentially being the cause. Similarly, YieldMax SMCI, which is not really a stock but an ETF, experienced losses of 36.9%. A congressional member bought this with an amount in the 15,000-50,000 range with little analyst coverage that had a negative earnings report. Finally, K2 Gold gets mentioned for the Bridget's Buy paper watchlist as a small company. No additional information is inferred.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  4. Market predictions extracted

    3 eligible signals linked to this case.

  5. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  6. Live evaluation in progress

    1 signal remains active.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

MarketBeat

Tracked signals
988
Historical success
42.8%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.